SAN CARLOS, Calif., Oct. 17, 2016 /PRNewswire/ -- LakePharma announced today it won nomination into The Fast 100: the
"LakePharma started in 2009 with no outside funding and only half of a single lab space. We wanted to develop a dedicated protein service business to reduce the inefficiencies in biotech discovery and development. Six years later, LakePharma has become the go-to biologics contract research organization for pharma and biotech companies, providing a full range of service in antibody and protein engineering, cell line development, and protein production," commented Hua Tu, founder and CEO. "Building a business takes a long time. It does not get any easier. We are extremely proud to be among The Fast 100 list. We could not have achieved this without valued customers and our phenomenal employees working hard every day to build the best system, revolutionize this industry and benefit the world."
Click here for more information on the Fast 100.
About LakePharma, Inc.
LakePharma is a leading US-based contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. Services can be fully integrated, creating a "soup to nuts" solution for all of a customer's molecular biology, cell line, and protein needs. With facilities located in the heart of the San Francisco Bay Area and near the Boston/Cambridge biotech hub, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to our customers. Our production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director and a project manager to ensure timely completion with superior results that meet or exceed our clients' expectations. For more information, visit www.lakepharma.com.
Corporate Communications ContactVickie Tu 650-288-4891
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lakepharma-among-the-fastest-growing-private-companies-in-the-bay-area-300345915.html
SOURCE LakePharma, Inc.
Subscribe to our Free Newsletters!
Adrenalectomy is a surgery that involves removing either one or both the adrenal glands.
Craniosynostosis is a condition where the bones of the skull are fused together prematurely ...
Episiotomy is a surgical incision made in the perineum between the vaginal orifice and the anus ...View All